Latest Breaking News On - Morris higham management - Page 4 : comparemela.com
The Associated Press
This Sept. 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson s long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot â not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. Johnson & Johnson said Friday, Jan. 29, 2021 that in the U.S. and seven other countries, the first single-shot vaccine appears 66% effective overall at preventing moderate to severe COVID-19. It was more protective against severe symptoms, 85%. (Cheryl Gerber/Johnson & Johnson via AP)
The first one-shot COVID-19 vaccine provides good protection against the illness, Johnson & Johnson reported in a key study released Friday, offering the world a potentially important new tool as it races to stay ahead of the rapidly mutating virus. The pharmaceutical giant’s preliminary findings suggest the single-dose option may not be as strong as
Staten-island
Alaska
United-states
Auckland
New-zealand
Australia
Texas
Florida
Delaware
South-africa
Seattle-university
Washington